|
From
the Laboratory of Serge Przedborski, MD,
PhD
Role of Endoplasmic Reticulum Stress in ALS Neurodegeneration
For the past decade, my laboratory at Columbia University has devoted
a significant part of its research effort to the study of the mechanisms
responsible for the demise of motor neurons in amyotrophic lateral sclerosis
(ALS). Investigations performed in several laboratories, including ours
have led to the conclusion that programmed cell death (PCD) was instrumental
in ALS neurodegeneration. PCD is an active form of cell
death that is highly regulated by a complex network of different molecules.
A more comprehensive review on the subject can be found in published
references. This program of cell suicide proceeds in a very strict
sequential manner, respecting a highly hierarchical molecular organization.
Mounting evidence has indicated that the caspase protease family plays
a central role in the implementation of PCD in vertebrates (Kaufmann
and Hengartner, 2001). These enzymes are constitutively (as normal
constituents) expressed in healthy cells, where they are synthesized
as precursor proteins (procaspases). Caspases are activated upon processing
of procaspases into many different pieces (approximately 20 kDa (p20)
and 10 kDa (p10) mature fragments, in addition to the N-terminal prodomain)
called the caspase family. This family is broadly divided into two groups:
initiator caspases (caspases-8, -9, and -12) and effector caspases (caspases-3,
-6, and –7). Initiator caspases undergo autoprocessing for activation
in response to PCD stimuli. Active initiator caspases in turn process
precursors of the effector caspases responsible for dismantling cellular
structures.
Recent studies have suggested the existence of a novel PCD pathway in
which caspase-12 functions as the initiator of cell death in response
to a stress in the endoplasmic reticulum (ER). ER in lay definition is
the factory for protein production in cells. Because of the potential
significance of this new molecular pathway both from a cell death mechanism
and therapeutic standpoints, my laboratory has embarked in the assessment
of ER stress in both human ALS and in its well-validated experimental
model provided by transgenic rodents expressing the mutant form of superoxide
dismutase-1 (SOD-1). To ascertain the role of ER stress in ALS motor
neuron degeneration Dr. Hitoshi Kikuchi in our laboratory decided to
determine the status of the three main ER pathways causing stress in
transgenic mutant SOD-1 mice. While these investigations are still ongoing,
he has already accumulated insightful information regarding the ER stress
machinery in ALS.
The vast majority of proteins in our cells exist, not as long straight
strings, but as folded cords. It is now well recognize that this complex
folding is essential for the proteins to exert their normal function.
Not only will misfolded proteins not function properly, but will also
not be well tolerated by the cell. Consequently, unless a cell gets rid
of misfolded proteins, it will die. One key function of the ER is to
detect the abnormal accumulation of misfolded proteins in the cell and
trigger the necessary mechanisms to get rid of them via what is called
the Unfolded Protein Response (UPR). In support of ER stress in ALS,
Dr. H. Kikuchi found mild UPR in spinal cords of affected transgenic
mutant SOD1 mice, evidenced by the increased amounts of two proteins
called Grp94 and Grp78/BiP. Indeed, Grp94 and Grp78/BiP are known to
be the two main proteins responsible in our cells for carrying on the
UPR.
If a cell is the site of accumulation of misfolded proteins, the ER
will attempt to protect the cell from further accumulation of toxic proteins
by blocking their production. This is achieved by the ER through activation
of a specific pathway that is regulated by a protein called PERK. In
contrast to the UPR, this second ER-dependent protective mechanism did
not appear to be recruited in this ALS model.
A third component is the ER-associated protein degradation, in which
the ER will attempt to protect the cell from further accumulation of
toxic proteins by stimulating the protein degradation by a complex cellular
machinery called the ubiquitin-proteasome system. This aspect of the
ER is still under investigation.
In response to ER stress, several cell death mechanisms are also recruited
which, ultimately lead to the cell demise in case of the ER-protective
mechanisms cited above have failed to protect the cell enough against
toxic misfolded proteins. These two killers are CHOP and caspase-12.
Dr. H. Kikuchi found that both of these death proteins are activated
in the ALS mice. Their activation is specifically observed in the spinal
cord of these animals and become stronger as the disease progresses.
Dr. H. Kikuchi has now obtained mutant mice deficient in CHOP and caspase-12
and is in the process of crossing these mutant animals with the transgenic
mutant SOD1 mice. Although these crossbreeding experiments are extremely
time-consuming, they should demonstrate whether or not CHOP and caspase-12
alterations are, as expected, important to the mechanism of motor neuron
death in ALS.
In parallel of these ER stress investigations in transgenic mutant SOD1
mice, Dr. H. Kikuchi has also studied post-mortem samples from ALS patients
for evidence of ER stress. So far, his results indicate that all ER stress
alterations found in the mice were also found in human ALS tissues, thus
supporting the relevance of the rodent data to elucidate the neurodegenerative
process in human ALS.
Until the next update, my laboratory staff and I send you and your families
a Happy New Year.
Serge Przedborski
|